A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2004
11/24/2004	EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms
11/24/2004	EP0856157B1 Tumour-specific p450 protein
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549734A Aromatase inhibition to enhance assisted reproduction
11/24/2004	CN1549723A Modified interleukin-1 receptor antagonist (IL-1RA) with reduced immunogenicity.
11/24/2004	CN1549721A Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/24/2004	CN1549719A Use of pregnane-diones or diols as neuropathic analgesic agents
11/24/2004	CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004	CN1549711A Use of condensed pyrrole compound in treatment of articular cartilage and bone tissue under cartilage degeneration
11/24/2004	CN1549707A Beta-adrenergic blockade reversal of catabolism after severe burn
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1549704A Stabilized oral suspension formulation
11/24/2004	CN1549703A 药物输送体系 Drug delivery system
11/24/2004	CN1548452A One kind of membrane protein of SARS coronavirus and its encoding gene and application
11/24/2004	CN1548157A SARS resisting medicine action target and its preventing and treating medicine
11/24/2004	CN1548055A Transdermic administrated external-use medicine composition
11/24/2004	CN1548054A Medicine for preventing and treatig SARS coronavirus
11/24/2004	CN1177002C Antimicrobial composition
11/24/2004	CN1176714C Method and composition for treating prostate cancer
11/24/2004	CN1176652C Application of demelani in diseases treatment
11/24/2004	CN1176650C Use of balufen in preparation of medicine for treating nicotine depondence
11/23/2004	US6822141 Diacylglycerol acyl transferase proteins
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822001 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
11/23/2004	US6821997 Associated with a decreased presence of cell-specific carbonic anhydrase enzymes; neurodegenerative conditions, dementia, alzheimer's disease; administering compound to increase ca such as forms of zinc
11/23/2004	US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004	US6821979 Synergistic enhancement of cognitive ability
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821946 Treating nerve damage; administer insulin like growth factor isoform to human, monitor response of damaged nerves
11/23/2004	US6821780 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
11/23/2004	US6821739 Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens
11/23/2004	US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004	US6821549 Contacting stent with a coating solution containing a coating material to be deposited on surface of stent; inserting thread through the lumen of the stent; producing relative motion between stent and thread to remove coating material
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/22/2004	CA2441681A1 Cancer monitoring and therapeutics
11/18/2004	WO2004098713A2 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
11/18/2004	WO2004098642A1 Migraine relief composition and methods of using and forming same
11/18/2004	WO2004098641A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
11/18/2004	WO2004098640A1 Use of combinations of reverse transcriptase inhibitors and virus coded dna polymerase inhibitors
11/18/2004	WO2004098638A1 Effector cell function inhibitor
11/18/2004	WO2004098637A1 Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency
11/18/2004	WO2004098633A1 Composition comprising a pde-4 inhibitor and a tnf alpha antagonist
11/18/2004	WO2004098618A2 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
11/18/2004	WO2004098617A2 Controlled release composition containing a strontium salt
11/18/2004	WO2004098615A1 Pharmaceutical composition for intraarticular application in tendon sheaths and periarticular bursae
11/18/2004	WO2004098613A1 Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics
11/18/2004	WO2004098612A2 Calcitriol analogs of uses thereof
11/18/2004	WO2004098611A1 Fortifier
11/18/2004	WO2004098606A1 Composition comprising a pde4 inhibitor and shuil-1r ii
11/18/2004	WO2004098604A1 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use
11/18/2004	WO2004098587A1 Mycophenolate mofetil in diabetic nephropathy
11/18/2004	WO2004098583A1 Combination comprising s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an hmg coa reductase inhibitor
11/18/2004	WO2004098580A2 A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
11/18/2004	WO2004098564A2 Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide
11/18/2004	WO2004098519A2 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity
11/18/2004	WO2004098509A2 Compositions for inducing immune responses
11/18/2004	WO2004087740A3 Preserved and stable compositions containing peptide copper complexes and methods related thereto
11/18/2004	WO2004082749A3 Medical devices with enhanced ultrasonic visibility
11/18/2004	WO2004078127A3 Continuous delivery methods for treating hepatitis virus infection
11/18/2004	WO2004048591A3 Methods for cohort selection and longevity studies
11/18/2004	WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004	WO2003093443A3 Alcam and alcam modulators
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040230257 Enhanced bioavailability of nutrients, pharmaceutical agents, and other bioactive substances through laser resonant homogenization or modification of molecular shape or crystalline form
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040229945 use in inhibiting angiogenesis in a mammal
11/18/2004	US20040229943 Analeptic and drug combinations
11/18/2004	US20040229940 Analeptic and antidepressant combinations
11/18/2004	US20040229928 Method for regulation of microvascular tone
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229901 For therapy of cardiac disease and/or renal failure
11/18/2004	US20040229886 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229857 Neurotherapeutic composition and method
11/18/2004	US20040229850 Method and kit for regulation of microvascular tone
11/18/2004	US20040229849 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229843 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229828 Administering a therapeutically effective amount of at least one pharmacologically acceptable oligonucleotide at least 10 nucleotides in length
11/18/2004	US20040229825 For therapy of infections with a drug resistant bacterium comprising disinfectant including a flavonoid which can enhance efficacy of a beta -lactam antibiotic
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229807 employing combination of an aP2 inhibitor and another antiatherosclerotic agent, for example, an HMG CoA reductase inhibitor such as pravastatin
11/18/2004	US20040229803 Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disorders
11/18/2004	US20040229801 Provides anti-fungal compounds, including peptides and peptidomimetics having anti-fungal activity alone, and in combination with other agents that have anti-fungal activity, and methods of using the compounds for killing or inhibit growth of yeast, mold, slimes
11/18/2004	US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229791 Modulating activity of growth factor in sample which contains an activated alpha 2-macroglobulin by contacting sample with fatty acid to inhibit formation of a complex between growth factor and activated alpha 2-macroglobulin, wherein the fatty acid binds to the activated alpha 2-macroglobulin
11/18/2004	US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

1 ... 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 ... 1151